Management of Complications in Anticoagulated Patients with Atrial Fibrillation | Zendy

George Katritsis | Zendy; Demosthenes G. Katritsis | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Management of Complications in Anticoagulated Patients with Atrial Fibrillation

Author(s) -

George Katritsis,

Demosthenes G. Katritsis

Publication year - 2017

Publication title -

arrhythmia and electrophysiology review

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.008

H-Index - 18

eISSN - 2050-3377

pISSN - 2050-3369

DOI - 10.15420/aer.2017.23.1

Subject(s) - medicine , atrial fibrillation , warfarin , stroke (engine) , anticoagulant , oral anticoagulant , rivaroxaban , major bleeding , cardiology , intensive care medicine , mechanical engineering , engineering

Oral anticoagulation is mandatory for patients at high risk of thromboembolism, but the risk of bleeding should also be taken into account. Direct oral anticoagulants are now recommended for non-valvular AF as a potential alternative to warfarin. In this article we discuss methods to assess the anticoagulant effect of these agents, specific and general antidotes, and management of complications such as embolic and haemorrhagic stroke, and significant bleeding.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research